1 asset in Optic Pathway Glioma
Therapeutic assets addressing Optic Pathway Glioma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Avutometinib Optic Pathway Glioma | Memorial Sloan Kettering Cancer Center | P1 | CC (43) |